{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:16:21Z","timestamp":1776928581334,"version":"3.51.2"},"reference-count":60,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone marrow cells (BMCs) could correct some pathologic conditions of the central nervous system (CNS) if these cells would effectively repopulate the brain. One such condition is GM1-gangliosidosis, a neurodegenerative glycosphingolipidosis due to deficiency of lysosomal \u03b2-galactosidase (\u03b2-gal). In this disease, abnormal build up of GM1-ganglioside in the endoplasmic reticulum of brain cells results in calcium imbalance, induction of an unfolded protein response (UPR), and neuronal apoptosis. These processes are accompanied by the activation\/proliferation of microglia and the production of inflammatory cytokines. Here we demonstrate that local neuroinflammation promotes the selective activation of chemokines, such as stromal-cell-derived factor 1 (SDF-1), macrophage inflammatory protein 1-\u03b1 (MIP-1\u03b1), and MIP-1\u03b2, which chemoattract genetically modified BMCs into the CNS. Mice that underwent bone marrow transplantation showed increased \u03b2-gal activity in different brain regions and reduced lysosomal storage. Decreased production of chemokines and effectors of the UPR as well as restoration of neurologic functions accompanied this phenotypic reversion. Our results suggest that \u03b2-gal-expressing bone marrow (BM)-derived cells selectively migrate to the CNS under a gradient of chemokines and become a source of correcting enzyme to deficient neurons. Thus, a disease condition such as GM1-gangliosidosis, which is characterized by neurodegeneration and neuroinflammation, may influence the response of the CNS to ex vivo gene therapy.<\/jats:p>","DOI":"10.1182\/blood-2005-03-1189","type":"journal-article","created":{"date-parts":[[2005,6,8]],"date-time":"2005-06-08T03:14:35Z","timestamp":1118200475000},"page":"2259-2268","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":70,"title":["Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology"],"prefix":"10.1182","volume":"106","author":[{"given":"Renata","family":"Sano","sequence":"first","affiliation":[{"name":"From the Department of Genetics and Tumor Cell Biology, Saint Jude Children's Research Hospital, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tessitore","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Tumor Cell Biology, Saint Jude Children's Research Hospital, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ingrassia","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Tumor Cell Biology, Saint Jude Children's Research Hospital, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"d'Azzo","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Tumor Cell Biology, Saint Jude Children's Research Hospital, Memphis, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021218263319700_REF1","doi-asserted-by":"crossref","unstructured":"Santamaria P. Cytokines and chemokines in autoimmune disease: an overview. Adv Exp Med Biol.2003;520: 1-7.","DOI":"10.1007\/978-1-4615-0171-8_1"},{"key":"2020021218263319700_","unstructured":"Stoll G, Jander S, Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol.2002;513: 87-113."},{"key":"2020021218263319700_REF3","doi-asserted-by":"crossref","unstructured":"Mennicken F, Maki R, de Souza EB, Quirion R. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci.1999;20: 73-78.","DOI":"10.1016\/S0165-6147(99)01308-5"},{"key":"2020021218263319700_REF4","doi-asserted-by":"crossref","unstructured":"Kremlev SG, Roberts RL, Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol.2004;149: 1-9.","DOI":"10.1016\/j.jneuroim.2003.11.012"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Gourmala NG, Limonta S, Bochelen D, Sauter A, Boddeke HW. Localization of macrophage inflammatory protein: macrophage inflammatory protein-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia. Neuroscience. 1999;88: 1255-1266.","DOI":"10.1016\/S0306-4522(98)00295-4"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Floridi F, Trettel F, Di Bartolomeo S, Ciooti MT, Limatola C. Signalling pathways involved in the chemotactic activity of CXCL-12 in cultured rat cerebellar neurons and CHP100 neuroephithelioma cells. J Neuroimmunol.2003;135: 38-46.","DOI":"10.1016\/S0165-5728(02)00432-0"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Banisadr G, Skrzydelski D, Kitabgi P, Rostene W, Parsadaniantz SM. Highly regionalized distribution of stromal cell-derived factor-1\/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci.2003;18: 1593-1606.","DOI":"10.1046\/j.1460-9568.2003.02893.x"},{"key":"2020021218263319700_REF8","doi-asserted-by":"crossref","unstructured":"Guo H, Jin YX, Ishikawa M, et al. Regulation of \u03b2-chemokine mRNA in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand J Immunol.1998;48: 502-508.","DOI":"10.1046\/j.1365-3083.1998.00422.x"},{"key":"2020021218263319700_REF9","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature. 1993;361: 79-82.","DOI":"10.1038\/361079a0"},{"key":"2020021218263319700_REF10","doi-asserted-by":"crossref","unstructured":"Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell.1994;76: 301-314.","DOI":"10.1016\/0092-8674(94)90337-9"},{"key":"2020021218263319700_REF11","unstructured":"Jones SA, Moser B, Thelen MA. A comparison of post-receptor signal transduction events in Jurkat cells with either IL-8R1 or IL-8R2: chemokine mediated activation of p42\/44 MAP-kinase (ERK-2). FEBS Lett.1996;364: 211-214."},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL. Interleukin-8 regulation of the Ras\/Raf\/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem.1996;271: 2382-2388.","DOI":"10.1074\/jbc.271.5.2832"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol.1997;15: 675-705.","DOI":"10.1146\/annurev.immunol.15.1.675"},{"key":"2020021218263319700_","unstructured":"Murphy PM, Baggiolini M, Charo IF, et al. International Union of Pharmacology XXII: nomenclature for chemokine receptors. Pharmacol Rev.2000; 52: 145-176."},{"key":"2020021218263319700_REF15","doi-asserted-by":"crossref","unstructured":"Rollins JB. Chemokines. Blood. 1997;90: 909-928.","DOI":"10.1182\/blood.V90.3.909"},{"key":"2020021218263319700_REF16","doi-asserted-by":"crossref","unstructured":"Babcock A, Owens T. Chemokines in experimental autoimmune encephalomyelitis and multiple sclerosis. Adv Exp Med Biol.2003;520: 120-132.","DOI":"10.1007\/978-1-4615-0171-8_8"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol.2001;22: 147-184.","DOI":"10.1006\/frne.2001.0214"},{"key":"2020021218263319700_REF18","doi-asserted-by":"crossref","unstructured":"Bajetto A, Bonavia R, Barbero S, Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem.2002;82: 1311-1329.","DOI":"10.1046\/j.1471-4159.2002.01091.x"},{"key":"2020021218263319700_REF19","doi-asserted-by":"crossref","unstructured":"Glabinski AR, Bielecki B, Ransohoff RM. Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis. Scand J Immunol.2003;58: 81-88.","DOI":"10.1046\/j.1365-3083.2003.01285.x"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Merrill JE, Murphy SP. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav Immun.1997;11: 245-263.","DOI":"10.1006\/brbi.1997.0496"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Weiss JM, Berman JW. Astrocyte expression of monocyte chemoattractant protein-1 is differentially regulated by transforming growth factor beta. J Neuroimmunol.1998;91: 190-197.","DOI":"10.1016\/S0165-5728(98)00183-0"},{"key":"2020021218263319700_REF22","doi-asserted-by":"crossref","unstructured":"Vaday GG, Franitza S, Schor H, et al. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol.2001;69: 885-892.","DOI":"10.1189\/jlb.69.6.885"},{"key":"2020021218263319700_REF23","doi-asserted-by":"crossref","unstructured":"Wu YP, Matsuda J, Kubota A, Suzuki K. Infiltration of hematogenous lineage cells into the demyelinating central nervous system of twitcher mice. J Neuropathol Exp Neurol.2000;59: 628-639.","DOI":"10.1093\/jnen\/59.7.628"},{"key":"2020021218263319700_REF24","doi-asserted-by":"crossref","unstructured":"Mizukami H, Yide M, Ryuichi W, et al. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest.2002;109: 215-221.","DOI":"10.1172\/JCI0214530"},{"key":"2020021218263319700_REF25","doi-asserted-by":"crossref","unstructured":"Wu YP, Proia RL. Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci U S A.2004;101: 8425-8430.","DOI":"10.1073\/pnas.0400625101"},{"key":"2020021218263319700_REF26","unstructured":"Suzuki Y, Oshima A, Nanba E. \u03b2-Galactosidase deficiency (\u03b2-galactosialidosis): GM1 gangliosidosis and morquio B disease. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. Vol 3. 8th ed. New York, NY: McGraw-Hill; 2001: 3775-3810."},{"key":"2020021218263319700_REF27","doi-asserted-by":"crossref","unstructured":"Hahn CN, Martin MP, Schroder M, et al. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid \u03b2-galactosidase. Hum Mol Gen.1997;6: 205-211.","DOI":"10.1093\/hmg\/6.2.205"},{"key":"2020021218263319700_REF28","doi-asserted-by":"crossref","unstructured":"Tessitore A, Martin MP, Sano R, et al. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell.2004;15: 753-766.","DOI":"10.1016\/j.molcel.2004.08.029"},{"key":"2020021218263319700_REF29","doi-asserted-by":"crossref","unstructured":"Jeyakumar M, Thomas R, Elliot-Smith E, et al. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain. 2003;126: 974-987.","DOI":"10.1093\/brain\/awg089"},{"key":"2020021218263319700_REF30","unstructured":"Hawley R, Lieu F, Fong A, Hawley T. Versatile retroviral vectors for potential use in gene therapy. Gene Ther.1994;1: 136-138."},{"key":"2020021218263319700_REF31","doi-asserted-by":"crossref","unstructured":"Persons DA, Allay JA, Allay ER, et al. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood. 1999;93: 488-499.","DOI":"10.1182\/blood.V93.2.488"},{"key":"2020021218263319700_REF32","unstructured":"Galjaard H. Genetic Metabolic Disease: Diagnosis and Prenatal Analysis. Amsterdam, the Netherlands: Elsevier Science Publishers BV; 1980."},{"key":"2020021218263319700_REF33","doi-asserted-by":"crossref","unstructured":"Ingram DK, London ED, Reynolds MA, Waller SB, Goodrick CL. Differential effects of age on motor performance in two mouse strains. Neurobiol Aging.1981;2: 221-227.","DOI":"10.1016\/0197-4580(81)90025-7"},{"key":"2020021218263319700_REF34","doi-asserted-by":"crossref","unstructured":"Holland HC, Weldon E. A note on a new technique of recording ambulation in the open field test and its validation. Acta Psychol (Amst). 1968; 28: 293-300.","DOI":"10.1016\/0001-6918(68)90020-6"},{"key":"2020021218263319700_REF35","doi-asserted-by":"crossref","unstructured":"Tilson HA, Cabe PA. Strategy for the assessment of neurobehavioral consequences of environmental factors. Environ Health Perspect. 1978;26: 287-299.","DOI":"10.1289\/ehp.7826287"},{"key":"2020021218263319700_REF36","doi-asserted-by":"crossref","unstructured":"Bajetto A, Barbero S, Bonavia R, et al. Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1\/2 pathway. J Neurochem.2001;77: 1226-1236.","DOI":"10.1046\/j.1471-4159.2001.00350.x"},{"key":"2020021218263319700_REF37","doi-asserted-by":"crossref","unstructured":"Zhou XY, Morreau H, Rottier R, et al. Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes Dev.1995;9: 2623-2634.","DOI":"10.1101\/gad.9.21.2623"},{"key":"2020021218263319700_REF38","doi-asserted-by":"crossref","unstructured":"Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol.1998;85: 33-43.","DOI":"10.1016\/S0165-5728(97)00267-1"},{"key":"2020021218263319700_REF39","doi-asserted-by":"crossref","unstructured":"Birdsall HH, Green DM, Trial J, et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation. 1997;95: 684-692.","DOI":"10.1161\/01.CIR.95.3.684"},{"key":"2020021218263319700_REF40","doi-asserted-by":"crossref","unstructured":"Pyo H, Joe E, Jung S, Lee SH, Jou I. Gangliosides activate cultured rat brain microglia. J Biol Chem.1999;274: 34584-34589.","DOI":"10.1074\/jbc.274.49.34584"},{"key":"2020021218263319700_REF41","doi-asserted-by":"crossref","unstructured":"Matyszak MK. Inflammation in the CNS: balance between inmmunological privilige and immune responses. Prog Neurol.1998;56: 19-35.","DOI":"10.1016\/S0301-0082(98)00014-8"},{"key":"2020021218263319700_REF42","doi-asserted-by":"crossref","unstructured":"Perry VH. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol.1998;90: 113-121.","DOI":"10.1016\/S0165-5728(98)00145-3"},{"key":"2020021218263319700_REF43","doi-asserted-by":"crossref","unstructured":"Eugenin EA, Berman JW. Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods. 2003; 29: 351-361.","DOI":"10.1016\/S1046-2023(02)00359-6"},{"key":"2020021218263319700_REF44","doi-asserted-by":"crossref","unstructured":"Ransohoff RM. The chemokine system in neuroinflammation: an update. J Infect Dis.2002; 186(suppl 2): S152-S156.","DOI":"10.1086\/344266"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Asensio VC, Campbell IL. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci.1999;22: 504-512.","DOI":"10.1016\/S0166-2236(99)01453-8"},{"key":"2020021218263319700_REF46","doi-asserted-by":"crossref","unstructured":"Meeuwsen S, Persoon-Deen C, Bsibsi M, Ravid R, van Noort JM. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia.2003;43: 243-253.","DOI":"10.1002\/glia.10259"},{"key":"2020021218263319700_REF47","doi-asserted-by":"crossref","unstructured":"Kim OS, Park EJ, Joe EH, Jou I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem.2002;277: 40594-40601.","DOI":"10.1074\/jbc.M203885200"},{"key":"2020021218263319700_REF48","doi-asserted-by":"crossref","unstructured":"Sellebjerg F, Sorensen TL. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull.2003;61: 347-355.","DOI":"10.1016\/S0361-9230(03)00097-2"},{"key":"2020021218263319700_REF49","doi-asserted-by":"crossref","unstructured":"Odemis V, Moepps B, Gierschik P, Engele J. Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression: implications for brain inflammation. J Biol Chem.2002;277: 39801-39808.","DOI":"10.1074\/jbc.M200472200"},{"key":"2020021218263319700_REF50","doi-asserted-by":"crossref","unstructured":"Pashenkov M, Soderstrom M, Link H. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. J Neuroimmunol.2003;135: 154-160.","DOI":"10.1016\/S0165-5728(02)00441-1"},{"key":"2020021218263319700_REF51","doi-asserted-by":"crossref","unstructured":"Little AR, Benkovic SA, Miller DB, O'Callaghan JP. Chemically induced neuronal damage and gliosis: enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines. Neuroscience. 2002; 115: 307-320.","DOI":"10.1016\/S0306-4522(02)00359-7"},{"key":"2020021218263319700_REF52","doi-asserted-by":"crossref","unstructured":"Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol.2000;26: 133-142.","DOI":"10.1046\/j.1365-2990.2000.026002133.x"},{"key":"2020021218263319700_REF53","doi-asserted-by":"crossref","unstructured":"Sorensen TL, Tani M, Jensen J, et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest.1999;103: 807-815.","DOI":"10.1172\/JCI5150"},{"key":"2020021218263319700_REF54","doi-asserted-by":"crossref","unstructured":"Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science. 2001; 294: 1933-1936.","DOI":"10.1126\/science.1064081"},{"key":"2020021218263319700_REF55","doi-asserted-by":"crossref","unstructured":"Medin JA, Megita M, Pawliu R, et al. A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients. Blood. 1996;87: 1754-1762.","DOI":"10.1182\/blood.V87.5.1754.1754"},{"key":"2020021218263319700_","doi-asserted-by":"crossref","unstructured":"Leimig T, Mann L, Martin MP, et al. Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood. 2002;99: 3169-3178.","DOI":"10.1182\/blood.V99.9.3169"},{"key":"2020021218263319700_REF57","doi-asserted-by":"crossref","unstructured":"Biffi A, de Palma M, Quattrini A, et al. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest.2004;113: 1118-1129.","DOI":"10.1172\/JCI200419205"},{"key":"2020021218263319700_REF58","doi-asserted-by":"crossref","unstructured":"d'Azzo A. Gene transfer strategies for correction of lysosomal storage disorders. Acta Haematol.2003;110: 71-85.","DOI":"10.1159\/000072456"},{"key":"2020021218263319700_REF59","unstructured":"Einerhand MP, Valerio D. Gene transfer into hematopoietic stem cells: prospects for human gene therapy. Curr Top Microbiol Immunol. 1992;177: 217-235."},{"key":"2020021218263319700_REF60","doi-asserted-by":"crossref","unstructured":"Rynditch AV, Zoubak S, Tsyba L, Tryapitsina-Guley N, Bernardi G. The regional integration of retroviral sequences into the mosaic genomes of mammals. Gene.1998;222: 1-16.","DOI":"10.1016\/S0378-1119(98)00451-X"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/7\/2259\/1635090\/zh801905002259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/7\/2259\/1635090\/zh801905002259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T13:03:40Z","timestamp":1706274220000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/7\/2259\/21675\/Chemokineinduced-recruitment-of-genetically"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-03-1189","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}